DOROTHY BAKER: Open Payments
NPI 1568403616 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,797 in 91 payments from 25 companies in 2025. Trend: 2023 $2,764 · 2024 $3,165 · 2025 $2,797
Food & beverage: $2,797
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $523 |
| Novo Nordisk Inc | 8 | $285 |
| Lilly USA, LLC | 13 | $269 |
| AstraZeneca Pharmaceuticals LP | 2 | $202 |
| Gilead Sciences, Inc. | 4 | $182 |
| Amgen Inc. | 3 | $174 |
| Kowa Pharmaceuticals America, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
| PFIZER INC. | 6 | $104 |
Products named: UBRELVY, VRAYLAR, Ozempic, REPATHA, QULIPTA, Yeztugo, ZORYVE, Auvelity.
Industry payments across KY — which companies pay providers there.
